Cargando…
The Impact of Biologic Treatment on PD-1/PD-L1 Pathway Disturbances in Psoriasis
The programmed death-1 (PD-1) receptor plays a major physiological role in the maintenance of immune tolerance and, by interaction with its ligands (PD-L1 and PD-L2), prevents the development of multiple immune-mediated diseases. There is growing evidence of the PD-1/PD-L1 pathway playing an importa...
Autores principales: | Adamczyk, Michał, Bartosińska, Joanna, Raczkiewicz, Dorota, Michalak-Stoma, Anna, Krasowska, Dorota |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10342355/ https://www.ncbi.nlm.nih.gov/pubmed/37445214 http://dx.doi.org/10.3390/jcm12134179 |
Ejemplares similares
-
The Expression of Activation Markers CD25 and CD69 Increases during Biologic Treatment of Psoriasis
por: Adamczyk, Michał, et al.
Publicado: (2023) -
Analysis of circulating soluble programmed death 1 (PD-1), neuropilin 1 (NRP-1) and human leukocyte antigen-G (HLA-G) in psoriatic patients
por: Bartosińska, Joanna, et al.
Publicado: (2018) -
PD1/PD-L1 pathway in psoriasis and psoriatic arthritis: a review
por: Adamczyk, Michał, et al.
Publicado: (2022) -
Multiple Cytokine Analysis of Th1/Th2/Th9/Th17/Th22/Treg Cytokine Pathway for Individual Immune Profile Assessment in Patients with Psoriasis
por: Michalak-Stoma, Anna, et al.
Publicado: (2022) -
Decreased blood CD4+PD-1+ and CD8+PD-1+ T cells in psoriatic patients with and without arthritis
por: Bartosińska, Joanna, et al.
Publicado: (2018)